PILA PHARMA AB

As of June 30, 2024, PILA PHARMA AB carries a market capitalization of 102.31M, placing it among publicly traded companies globally. Its enterprise value stands at 99.77M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

PILA PHARMA AB's next confirmed earnings release is scheduled for February 25, 2027.

As of June 30, 2024, PILA PHARMA AB has 26.67M shares outstanding.

These figures are as of June 30, 2024.

As of June 30, 2024, PILA PHARMA AB maintains a current ratio of 1.47, meaning it holds 1.5x the short-term assets needed to cover near-term liabilities.

These figures cover the twelve months ended June 30, 2024.

As of the close on October 22, 2026, PILA PHARMA AB's stock has declined approximately 28.15% over the past 52 weeks. The 50-day moving average sits at 1.71, while the 200-day moving average is 1.52.

As of June 30, 2024, PILA PHARMA AB holds 2.54M in cash and equivalents against - - in total debt, resulting in a net debt position of -2.54M. Total book value stands at 2.58M, with working capital of 894,000.00 providing operational flexibility.

PILA PHARMA AB's most recent stock split took place on June 26, 2025.